Bajaj Healthcare reports Q4 net loss of ₹22.9 crore, recommends final dividend
Bajaj Healthcare reported a net profit of ₹11.17 crore for the fourth quarter of fiscal year 2025, marking a turnaround from a loss in the previous year. Despite a 15.4% year-on-year increase in revenue, the company experienced a 26.7% decline in EBITDA, leading to a contraction in its EBITDA margin. The board also recommended a final dividend of ₹1 per equity share for FY25.
May 08 2026 22:00:49
Bajaj Healthcare reports Q4 net loss of ₹22.9 crore, recommends final dividend
Bajaj HealthCare Limited announced its Q4 FY26 financial results, reporting a net loss of ₹22.9 crore. Concurrently, the company's board has recommended a final dividend for the financial year 2025-26.
May 08 2026 22:00:49
Bajaj Healthcare Ltd - 539872 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Bajaj Healthcare's Board of Directors approved the audited standalone financial results for the fourth quarter and full financial year ended March 31, 2026. The board also recommended a final dividend of Rs. 1.50 per equity share for FY26.
May 08 2026 20:55:54
Bajaj Healthcare Ltd - 539872 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 08Th May 2026
Bajaj Healthcare Board approved Q4 FY26 standalone financial results, reporting revenue of ₹153.06 crore (down 0.91% YoY) and a net loss of ₹22.85 crore. The board also recommended a final dividend of ₹1.50 per equity share for FY26 and appointed new internal and cost auditors for FY27.
May 08 2026 20:31:14
Bajaj Healthcare Limited
Bajaj Healthcare received listing approvals from NSE and BSE for 2,079,409 equity shares of Rs. 5 face value. These shares were allotted pursuant to the conversion of convertible warrants issued on a preferential basis at Rs. 338 per share.
May 07 2026 12:14:26
Read More